Androgens promote prostate cancer cell growth through induction of autophagy

Molecular Endocrinology

Volumn 27, Issue 2, 2013, Pages 280-295

  Shi, Yan ^a,b   Han, Jenny J ^a,b   Tennakoon, Jayantha B ^a,b   Mehta, Fabiola F ^a,b   Merchant, Fatima A ^b   Burns, Alan R ^c   Howe, Matthew K ^d   McDonnell, Donald P ^d   Frigo, Daniel E ^a,b  

^a University of Houston   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENTARY DNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ARTICLE; AUTOPHAGY; CANCER GROWTH; CELL CULTURE; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIPID STORAGE; LIPOGENESIS; MALE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANDROGENS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LIPID METABOLISM; LIPIDS; LIPOGENESIS; MALE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84873036325     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1260     Document Type: Article

References (92)

1. Gao W, Dalton JT 2007 Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today 12:241-248
2. Culig Z, Bartsch G 2006 Androgen axis in prostate cancer. J Cell Biochem 99:373-381
3. Levine B, Kroemer G 2008 Autophagy in the pathogenesis of disease. Cell 132:27-42
4. Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B, Yi Y, Magnuson MA, Roy-Burman P, Matusik RJ, Shappell SB, Hayward SW 2010 Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy. Cell Death Differ 17:469-481
5. Mizushima N, Levine B 2010 Autophagy in mammalian development and differentiation. Nat Cell Biol 12:823-830
6. Rabinowitz JD, White E 2010 Autophagy and metabolism. Science 330:1344-1348
7. Kondo Y, Kanzawa T, Sawaya R, Kondo S 2005 The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726-734
8. Mathew R, Karantza-Wadsworth V, White E 2007 Role of autophagy in cancer. Nat Rev Cancer 7:961-967
9. Hippert MM, O'Toole PS, Thorburn A 2006 Autophagy in cancer: good, bad, or both? Cancer Res 66:9349-9351
10. Yue Z, Jin S, Yang C, Levine AJ, Heintz N 2003 Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100:15077-15082
11. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B 2003 Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809-1820
12. Feng Z, Zhang H, Levine AJ, Jin S 2005 The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102:8204-8209
13. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, Ogier-Denis E 2001 The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/ protein kinase B pathway. J Biol Chem 276:35243-35246
14. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB 2007 Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326-336
15. Bauvy C, Gane P, Arico S, Codogno P, Ogier-Denis E 2001 Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp Cell Res 268:139-149
16. Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Métivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G 2005 Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25:1025-1040
17. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V, Coller HA, Dipaola RS, Gelinas C, Rabinowitz JD, White E 2011 Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:460-470
18. Kim MJ, Woo SJ, Yoon CH, Lee JS, An S, Choi YH, Hwang SG, Yoon G, Lee SJ 2011 Involvement of autophagy in oncogenic KRas-induced malignant cell transformation. J Biol Chem 286:12924-12932
19. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H 2009 Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol 16:761-771
20. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB 2007 The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 9:218-224
21. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, Liao WS, Bast Jr RC 2008 The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 118:3917-3929
22. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H, Zha Z, Liu Y, Li Z, Xu Y, Wang G, Huang Y, Xiong Y, Guan KL, Lei QY 2011 Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 42:719-730
23. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP 2010 The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 9:3485-3505
24. Sotelo J, Briceño E, López-González MA 2006 Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:337-343
25. Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL 2011 Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 25:1510-1527
26. Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, Mautner J, Tonon G, Haigis M, Shirihai OS, Doglioni C, Bardeesy N, Kimmelman AC 2011 Pancreatic cancers require autophagy for tumor growth. Genes Dev 25:717-729
27. Lazova R, Camp RL, Klump V, Siddiqui SF, Amaravadi RK, Pawelek JM 2012 Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 18:370-379
28. White E, DiPaola RS 2009 The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15:5308-5316
29. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M 2009 Autophagy is required to maintain muscle mass. Cell Metab 10:507-515
30. Masiero E, Sandri M 2010 Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles. Autophagy 6:307-309
31. Goldman S, Zhang Y, Jin S 2010 Autophagy and adipogenesis: implications in obesity and type II diabetes. Autophagy 6:179-181
32. Zhang Y, Goldman S, Baerga R, Zhao Y, Komatsu M, Jin S 2009 Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc Natl Acad Sci USA 106:19860-19865
33. Baerga R, Zhang Y, Chen PH, Goldman S, Jin S 2009 Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice. Autophagy 5:1118-1130
34. Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ, Czaja MJ 2009 Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 119:3329-3339
35. Shibata M, Yoshimura K, Furuya N, Koike M, Ueno T, Komatsu M, Arai H, Tanaka K, Kominami E, Uchiyama Y 2009 The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem Biophys Res Commun 382:419-423
36. Swinnen JV, Brusselmans K, Verhoeven G 2006 Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 9:358-365
37. Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, de la Taille A, Culine S, Blancou H, Cristol JP, Michel F, Sardet C, Fajas L 2010 Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 9:1740-1754
38. Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, Van Veldhoven PP, Waltregny D, Daniëls VW, Machiels J, Vanderhoydonc F, Smans K, Waelkens E, Verhoeven G, Swinnen JV 2010 De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 70:8117-8126
39. Liu Y, Zuckier LS, Ghesani NV 2010 Dominant uptake of fatty acid over glucose by prostate cells: a potential new diagnostic and therapeutic approach. Anticancer Res 30:369-374
40. Zha S, Ferdinandusse S, Hicks JL, Denis S, Dunn TA, Wanders RJ, Luo J, De Marzo AM, Isaacs WB 2005 Peroxisomal branched chain fatty acid β-oxidation pathway is upregulated in prostate cancer. Prostate 63:316-323
41. Flavin R, Zadra G, Loda M 2011 Metabolic alterations and targeted therapies in prostate cancer. J Pathol 223:283-294
42. Baron A, Migita T, Tang D, Loda M 2004 Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91:47-53
43. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E, Fiore C, Xie W, Kung AL, Febbo PG, Subramanian A, Mucci L, Ma J, Signoretti S, Stampfer M, Hahn WC, Finn S, Loda M 2009 Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101:519-532
44. Pflug BR, Pecher SM, Brink AW, Nelson JB, Foster BA 2003 Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model. Prostate 57:245-254
45. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB 2005 ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8:311-321
46. Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV 2007 Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res 67:8180-8187
47. Swinnen JV, Heemers H, van de Sande T, de Schrijver E, Brusselmans K, Heyns W, Verhoeven G 2004 Androgens, lipogenesis and prostate cancer. J Steroid Biochem Mol Biol 92:273-279
48. Lin H, Lu JP, Laflamme P, Qiao S, Shayegan B, Bryskin I, Monardo L, Wilson BC, Singh G, Pinthus JH 2010 Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies. Int J Oncol 37:761-766
49. Frigo DE, McDonnell DP 2008 Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation. Mol Cancer Ther 7:659-669
50. Kimura S, Noda T, Yoshimori T 2007 Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3:452-460
51. Dwyer MA, Joseph JD, Wade HE, Eaton ML, Kunder RS, Kazmin D, Chang CY, McDonnell DP 2010 WNT11 expression is induced by estrogen-related receptor α and β-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res 70:9298-9308
52. Sherk AB, Frigo DE, Schnackenberg CG, Bray JD, Laping NJ, Hammond M, Patterson J, Thompson SK, Kazmin D, Norris JD, McDonnell DP 2008 Development of a small molecule serum and glucocorticoid-regulated kinase 1 antagonist and its evaluation as a prostate cancer therapeutic. Cancer Res 68:1-9
53. Frigo DE, Howe MK, Wittmann BM, Brunner AM, Cushman I, Wang Q, Brown M, Means AR, McDonnell DP 2011 CaM kinase kinase β-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. Cancer Res 71:528-537
54. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, et al. 2008 Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151-175
55. Mizushima N, Yoshimori T 2007 How to interpret LC3 immunoblotting. Autophagy 3:542-545
56. Altman BJ, Wofford JA, Zhao Y, Coloff JL, Ferguson EC, Wieman HL, Day AE, Ilkayeva O, Rathmell JC 2009 Autophagy provides nutrients but can lead to Chop-dependent induction of Bim to sensitize growth factor-deprived cells to apoptosis. Mol Biol Cell 20:1180-1191
57. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T, Schmitt EM, Bernardi RJ, Fu X, Bland CS, Cooper TA, Schiff R, Rosen JM, Westbrook TF, Elledge SJ 2011 The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 108:3665-3670
58. Veeramani S, Yuan TC, Lin FF, Lin MF 2008 Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene 27:5057-5068
59. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK 2008 Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 68:1777-1785
60. Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, Nebreda AR 2007 p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11:191-205
61. Knudsen KE, Scher HI 2009 Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer. Clin Cancer Res 15:4792-4798
62. Chhipa RR, Wu Y, Ip C 2011 AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia. Cell Signal 23:1466-1472
63. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes HM, Al-Zeer MA, Albert ML, Albin RL, Alegre-Abarrategui J, Aleo MF, Alirezaei M, Almasan A, Almonte-Becerril M, Amano A, et al. 2012 Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445-544
64. Mizushima N, Yoshimori T, Levine B 2010 Methods in mammalian autophagy research. Cell 140:313-326
65. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ 2009 Autophagy regulates lipid metabolism. Nature 458:1131-1135
66. Sinha RA, You SH, Zhou J, Siddique MM, Bay BH, Zhu X, Privalsky ML, Cheng SY, Stevens RD, Summers SA, Newgard CB, Lazar MA, Yen PM 2012 Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest 122:2428-2438
67. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T 2000 LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720-5728
68. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E 2005 Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1:84-91
69. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T 2007 p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131-24145
70. Heaton NS, Randall G 2010 Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8:422-432
71. Le Lay S, Briand N, Blouin CM, Chateau D, Prado C, Lasnier F, Le Liepvre X, Hajduch E, Dugail I 2010 The lipoatrophic caveolin-1 deficient mouse model reveals autophagy in mature adipocytes. Autophagy 6:754-763
72. Shin KJ, Wall EA, Zavzavadjian JR, Santat LA, Liu J, Hwang JI, Rebres R, Roach T, Seaman W, Simon MI, Fraser ID 2006 A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc Natl Acad Sci USA 103:13759-13764
73. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV 2001 Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15:1817-1828
74. Heemers H, Vanderhoydonc F, Roskams T, Shechter I, Heyns W, Verhoeven G, Swinnen JV 2003 Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo. Mol Cell Endocrinol 205:21-31
75. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z 2007 Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26:1749-1760
76. Huang WC, Li X, Liu J, Lin J, Chung LW 2012 Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res 10:133-142
77. Veeramani S, Chou YW, Lin FC, Muniyan S, Lin FF, Kumar S, Xie Y, Lele SM, Tu Y, Lin MF 2012 Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radic Biol Med 53:95-108
78. Mizushima N, Levine B, Cuervo AM, Klionsky DJ 2008 Autophagy fights disease through cellular self-digestion. Nature 451:1069-1075
79. Bennett HL, Fleming JT, O'Prey J, Ryan KM, Leung HY 2010 Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells. Cell Death Dis 1:e72
80. Li M, Jiang X, Liu D, Na Y, Gao GF, Xi Z 2008 Autophagy protects LNCaP cells under androgen deprivation conditions. Autophagy 4:54-60
81. Ray PD, Huang BW, Tsuji Y 2012 Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24:981-990
82. Klionsky DJ, Baehrecke EH, Brumell JH, Chu CT, Codogno P, Cuervo AM, Debnath J, Deretic V, Elazar Z, Eskelinen EL, Finkbeiner S, Fueyo-Margareto J, Gewirtz D, Jäättelä M, Kroemer G, Levine B, Melia TJ, Mizushima N, Rubinsztein DC, Simonsen A, Thorburn A, Thumm M, Tooze SA 2011 A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy 7:1273-1294
83. Sarker D, Reid AH, Yap TA, de Bono JS 2009 Targeting the PI3K/ AKT pathway for the treatment of prostate cancer. Clin Cancer Res 15:4799-4805
84. Brusselmans K, Timmermans L, Van de Sande T, Van Veldhoven PP, Guan G, Shechter I, Claessens F, Verhoeven G, Swinnen JV 2007 Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. J Biol Chem 282:18777-18785
85. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP 2006 Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66:2815-2825
86. Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS 2007 Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res 67:5033-5041
87. Locke JA, Guns ES, Lubik AA, Adomat HH, Hendy SC, Wood CA, Ettinger SL, Gleave ME, Nelson CC 2008 Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Res 68:6407-6415
88. Kotzerke J, Volkmer BG, Neumaier B, Gschwend JE, Hautmann RE, Reske SN 2002 Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 29:1380-1384
89. Liu Y 2006 Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis 9:230-234
90. Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y, Sadato N, Yamamoto K, Okada K 2002 11C-acetate PET imaging of prostate cancer. J Nucl Med 43:181-186
91. Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, Kibel AS, Andriole GL, Picus J, Welch MJ 2003 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 44:549-555
92. Pinthus JH, Lu JP, Bidaisee LA, Lin H, Bryskine I, Gupta RS, Singh G 2007 Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer. Prostate 67:1330-1338